Early bird registration is open and closes May 2025. Register now

Abstracts deadline EXTENDED Friday 22 May 2026! Submit now

d
h
m
s

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. www.takeda.com

Share

Key dates

Registrations
Abstracts

More Partners / Exhibitors

Johnson & Johnson Innovative Medicine Korea

Johnson & Johnson Innovative Medicine Korea

Novartis

UCB

LG Chem

Samsung Bioepis

Astellas Pharma Korea Inc.

Days
Hours
Minutes
Seconds
Until 11:59PM AEST Friday 24 April, 2026

The countdown is on

Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.